The results support the use of atorvastatin soon after a stroke or TIA, the researchers said. The FDA has approved Pfizer’s atorvastatin calcium (Lipitor) for use in children aged 10 to 17 with familial hypercholesterolemia. The research team randomly assigned (concealed allocation) patients to receive atorvastatin lipitor atorvastatin 10 mg daily (n=1428) or placebo (n=1410), regardless of lipid levels. Pfizer’s also testing patient care centers lipitor atorvastatin at Walgreens in Indianapolis. Lipitor is the Only Statin to Have Been Studied Solely in Patients with Recent Stroke or Mini-stroke NEW ORLEANS — Pfizer announced lipitor atorvastatin today that Lipitor([R]) (atorvastatin calcium) Tablets 10 mg provided a significant 61 percent reduction in stroke in patients with type 2 diabetes and metabolic syndrome but without heart disease. Compared with those treated with 10 mg atorvastatin (Lipitor; Pfizer), the 80 mg treated group had a reduction in major cardiovascular events of 22% (25% for the sub-group with diabetes) after 5 years. RECOMMENDATIONS FOR CLINICAL PRACTICE Atorvastatin 80 mg per day started within 96 hours of non-Q-wave AMI or unstable angina (ACS) reduces recurrent ischemic events requiring rehospitalization during the first 16 weeks of treatment. This is because the degree of nonlinearity going up the curve will probably not be identical to the degree of nonlinearity going down the curve. * POPULATION STUDIED The population studied included 3086 adults 18 years or older with unstable angina or non-Q-wave acute myocardial infarction (AMI). It (the U. * Lipitor 10 mg provided a significant 61 percent reduction in the risk of stroke compared with placebo. In a clinical study of adolescent boys and girls with hypercholesterolemia, patients treated lipitor atorvastatin with atorvastatin had adverse events similar to those of placebo patients. Drugs on the preferred list have lower copayments than competing medicines, making them more attractive to consumers. The benefits of Lipitor 80 mg in patients with a recurrent stroke or mini-stroke seen in this analysis are consistent with the primary SPARCL results which demonstrated the benefit of Lipitor 80 mg in reducing stroke and coronary events among all patients in the study (n=4,731). "As physicians, payers and employers come under increasing pressure to reduce medical healthcare costs, this analysis provides them with additional support for offering intensive Lipitor therapy to help achieve improved and cost-effective cardiovascular outcomes for their patients," said Dr. Its central research focus is on heart disease, diabetes, stroke, anti-infectives, central nervous system, cancer and women’s health care. The approval follows a review of the Lipitor(R) new drug application by the special committee of the Central Pharmaceutical Affairs Council in Japan. These results are likely to be a lipitor atorvastatin class effect and not drug specific. Walking until the pain starts, stopping until lipitor atorvastatin the pain goes away, and then walking some more can help build up your stamina. Pravachol, which is made by Bristol- Myers Squibb Co. , is also losing patent protection next year. The most common adverse events in both groups were infections. We are pleased that the committee recognized the therapeutic benefits of Lipitor(R) and we look forward to introducing the drug in Japan with our partner, Yamanouchi, said Anthony H. Torcetrapib raises HDL levels; therefore, it should prevent coronary disease.